导管内乳头状黏液性肿瘤切除术后的复发:一项指导监测的系统评价
Recurrence following Resection of Intraductal Papillary Mucinous Neoplasms: A Systematic Review to Guide Surveillance.
作者信息
Salahuddin Aneesa, Thayaparan Varna, Hamad Ahmad, Tarver Willi, Cloyd Jordan M, Kim Alex C, Gebhard Robyn, Pawlik Timothy M, Reames Bradley N, Ejaz Aslam
机构信息
Department of Surgery, The Ohio State University, Columbus, OH 43210, USA.
Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
出版信息
J Clin Med. 2024 Jan 31;13(3):830. doi: 10.3390/jcm13030830.
Patients who undergo resection for non-invasive IPMN are at risk for long-term recurrence. Further evidence is needed to identify evidence-based surveillance strategies based on the risk of recurrence. We performed a systematic review of the current literature regarding recurrence patterns following resection of non-invasive IPMN to summarize evidence-based recommendations for surveillance. Among the 61 studies reviewed, a total of 8779 patients underwent resection for non-invasive IPMN. The pooled overall median follow-up time was 49.5 months (IQR: 38.5-57.7) and ranged between 14.1 months and 114 months. The overall median recurrence rate for patients with resected non-invasive IPMN was 8.8% (IQR: 5.0, 15.6) and ranged from 0% to 27.6%. Among the 33 studies reporting the time to recurrence, the overall median time to recurrence was 24 months (IQR: 17, 46). Existing literature on recurrence rates and post-resection surveillance strategies for patients with resected non-invasive IPMN varies greatly. Patients with resected non-invasive IPMN appear to be at risk for long-term recurrence and should undergo routine surveillance.
接受非侵袭性胰管内乳头状黏液性肿瘤(IPMN)切除术的患者存在长期复发风险。需要更多证据来确定基于复发风险的循证监测策略。我们对当前关于非侵袭性IPMN切除术后复发模式的文献进行了系统综述,以总结循证监测建议。在纳入综述的61项研究中,共有8779例患者接受了非侵袭性IPMN切除术。汇总后的总体中位随访时间为49.5个月(四分位间距:38.5 - 57.7),范围在14.1个月至114个月之间。接受非侵袭性IPMN切除术患者的总体中位复发率为8.8%(四分位间距:5.0,15.6),范围从0%至27.6%。在33项报告复发时间的研究中,总体中位复发时间为24个月(四分位间距:17,46)。关于接受非侵袭性IPMN切除术患者的复发率和切除术后监测策略的现有文献差异很大。接受非侵袭性IPMN切除术的患者似乎存在长期复发风险,应接受常规监测。